-+ 0.00%
-+ 0.00%
-+ 0.00%

Bright Minds Biosciences to Announce Phase 2 BMB-101 Trial Results for Absence Seizures and Epileptic Encephalopathies

Reuters·01/05/2026 21:30:23

Please log in to view news